-
Signature
-
/s/ Bruce Posey by power of attorney for Sumedh S. Thakar
-
Issuer symbol
-
QLYS
-
Transactions as of
-
29 May 2025
-
Net transactions value
-
-$992,422
-
Form type
-
4
-
Filing time
-
02 Jun 2025, 17:23:08 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Thakar Sumedh S |
CEO & PRESIDENT, Director |
C/O QUALYS, INC., 919 E. HILLSDALE BLVD., FOSTER CITY |
/s/ Bruce Posey by power of attorney for Sumedh S. Thakar |
02 Jun 2025 |
0001558242 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
QLYS |
Common Stock |
Options Exercise |
$166,140 |
+6,500 |
+2.7% |
$25.56 |
246,462 |
29 May 2025 |
Direct |
F1 |
| transaction |
QLYS |
Common Stock |
Sale |
$352,357 |
-2,602 |
-1.1% |
$135.42 |
243,860 |
29 May 2025 |
Direct |
F1, F2 |
| transaction |
QLYS |
Common Stock |
Sale |
$547,895 |
-4,014 |
-1.6% |
$136.50 |
239,846 |
29 May 2025 |
Direct |
F1, F3 |
| transaction |
QLYS |
Common Stock |
Sale |
$258,311 |
-1,884 |
-0.79% |
$137.11 |
237,962 |
29 May 2025 |
Direct |
F1, F4 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
QLYS |
Stock Option (right to buy) |
Options Exercise |
$0 |
-6,500 |
-12% |
$0.000000 |
45,500 |
29 May 2025 |
Common Stock |
6,500 |
$25.56 |
Direct |
F5 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: